Investigative and Clinical Urology

The Korean Urological Association (대한비뇨의학회)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Significance of Preoperative C-Reactive Protein Elevation and Thrombocytosis in Patients with Non-Metastatic Renal Cell Carcinoma

  • Cho, Dae-Sung (Department of Urology, Ajou University School of Medicine) ;
  • Kim, Se-Joong (Department of Urology, Ajou University School of Medicine) ;
  • Lee, Soo-Hyung (Department of Urology, Ajou University School of Medicine) ;
  • Ahn, Hyun-Soo (Department of Urology, Ajou University School of Medicine) ;
  • Kim, Young-Soo (Department of Urology, Ajou University School of Medicine) ;
  • Kim, Sun-Il (Department of Urology, Ajou University School of Medicine)
  • Published : 2011.02.22
⟨ Previous Next ⟩

Abstract

Purpose: The aim of this study was to investigate the association of preoperative C-reactive protein (CRP) elevation and thrombocytosis with the prognosis of patients with non-metastatic renal cell carcinoma (RCC). Materials and Methods: This was a retrospective review of the medical records of 177 patients (130 men and 47 women) with non-metastatic RCC who underwent a radical nephrectomy between March 2000 and May 2008 and for whom preoperative CRP and platelet data were available for analysis. Preoperative CRP elevation and thrombocytosis were compared with clinical and pathological variables. Results: There were 38 patients with CRP elevation and 11 patients with thrombocytosis. The mean follow-up time was 48.3 months (median, 48.0; range, 13-111 months). Twenty-three patients (13.0%) developed metastases and six patients died during the follow-up period. CRP elevation was significantly correlated with anemia (p=0.001), T stage (p=0.004), grade (p=0.025), and metastasis (p<0.001). Thrombocytosis was significantly correlated with anemia (p=0.003), T stage (p=0.002), and metastasis (p=0.001). The univariate analysis identified anemia, CRP elevation, thrombocytosis, tumor histology subtype, tumor size, T stage, and grade as significant prognostic factors associated with recurrence-free survival, whereas the multivariate analyses showed that CRP elevation (p=0.033) and tumor size (p=0.007) were independent prognostic factors. Conclusions: Preoperative CRP elevation and thrombocytosis were associated with a poorer prognosis and a higher recurrence rate in patients with non-metastatic RCC. Moreover, preoperative CRP elevation appeared to be an independent predictor of tumor recurrence and prognosis. Preoperative thrombocytosis, however, was not an independent prognostic factor for tumor recurrence and prognosis.

Keywords

References

  1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29. https://doi.org/10.3322/canjclin.54.1.8
  2. Gudbjartsson T, Thoroddsen A, Petursdottir V, Hardarson S, Magnusson J, Einarsson GV. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology 2005;66:1186-91. https://doi.org/10.1016/j.urology.2005.07.009
  3. Ljungberg B, Alamdari FI, Stenling R, Roos G. Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 1999;36:565-9. https://doi.org/10.1159/000020049
  4. Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998;159:1163-7. https://doi.org/10.1016/S0022-5347(01)63541-9
  5. Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005;173:48-51. https://doi.org/10.1097/01.ju.0000148261.19532.2c
  6. Lee SE, Byun SS, Han JH, Han BK, Hong SK. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma. BJU Int 2006;98:1228-32. https://doi.org/10.1111/j.1464-410X.2006.06437.x
  7. Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer 2008;113:450-60. https://doi.org/10.1002/cncr.23566
  8. Kwon WA, Park C, Kim EJ, Ha YS, Kim YJ, Yun SJ, et al. The relationship between RUNX3 inactivation and its pathological features in renal cell carcinoma. Korean J Urol 2009;50:432-8. https://doi.org/10.4111/kju.2009.50.5.432
  9. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45. https://doi.org/10.1016/S0140-6736(00)04046-0
  10. Casamassima A, Picciariello M, Quaranta M, Berardino R, Ranieri C, Paradiso A, et al. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy. J Urol 2005;173:52-5. https://doi.org/10.1097/01.ju.0000146713.50673.e5
  11. Mitus AJ, Schafer AI. Thrombocytosis and thrombocythemia. Hematol Oncol Clin North Am 1990;4:157-78.
  12. Pedersen LM, Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 1996;9:1826-30. https://doi.org/10.1183/09031936.96.09091826
  13. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002;9:287-91. https://doi.org/10.1007/BF02573067
  14. Gogus C, Baltaci S, Filiz E, Elhan A, Beduk Y. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma. Urology 2004;63:447-50. https://doi.org/10.1016/j.urology.2003.10.039
  15. Ito K, Asano T, Yoshii H, Satoh A, Sumitomo M, Hayakawa M. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma. Int J Urol 2006;13:1365-70. https://doi.org/10.1111/j.1442-2042.2006.01563.x
  16. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. American joint committee on cancer staging manual. 6th ed. New York: Springer-Verlag; 2002;323-8.
  17. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63. https://doi.org/10.1097/00000478-198210000-00007
  18. Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med 1992;37:313-36.
  19. Yoshida N, Ikemoto S, Narita K, Sugimura K, Wada S, Yasumoto R, et al. Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma. Br J Cancer 2002;86:1396-400. https://doi.org/10.1038/sj.bjc.6600257
  20. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, et al. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989;250:607-10. https://doi.org/10.1016/0014-5793(89)80805-1
  21. Guillem P, Triboulet JP. Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus 2005;18:146-50. https://doi.org/10.1111/j.1442-2050.2005.00474.x
  22. Kodama J, Miyagi Y, Seki N, Tokumo K, Yoshinouchi M, Kobashi Y, et al. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999;82:107-10. https://doi.org/10.1016/S0301-2115(98)00227-9
  23. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998;176:335-8. https://doi.org/10.1016/S0002-9610(98)00204-9
  24. Hwang IC, Chang SG. Clinical significance of serum C-reactive protein in patients with renal cell carcinoma. Korean J Urol 1999;40:864-8.
  25. Komai Y, Saito K, Sakai K, Morimoto S. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. BJU Int 2007;99:77-80. https://doi.org/10.1111/j.1464-410X.2006.06497.x
  26. Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, et al. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992;52:3317-22.
  27. Ramakrishnan S, Xu FJ, Brandt SJ, Niedel JE, Bast RC Jr, Brown EL. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest 1989;83:921-6. https://doi.org/10.1172/JCI113977
  28. Hollen CW, Henthorn J, Koziol JA, Burstein SA. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 1991;79:286-90. https://doi.org/10.1111/j.1365-2141.1991.tb04534.x
  29. Karakiewicz PI, Trinh QD, Lam JS, Tostain J, Pantuck AJ, Belldegrun AS, et al. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality. Eur Urol 2007;52:1428-36. https://doi.org/10.1016/j.eururo.2007.03.036

Cited by

  1. Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies vol.6, pp.1, 2011, https://doi.org/10.1002/prca.201100062
  2. Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma vol.3, pp.2, 2011, https://doi.org/10.3892/ol.2011.511
  3. Pretreatment Thrombocytosis as a Prognostic Factor in Women with Gynecologic Malignancies: a Meta-analysis vol.13, pp.12, 2011, https://doi.org/10.7314/apjcp.2012.13.12.6077
  4. Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series vol.31, pp.5, 2011, https://doi.org/10.1007/s00345-012-0931-0
  5. Prognostic Significance of C-reactive Protein in Urological Cancers: a Systematic Review and Meta-analysis vol.15, pp.8, 2011, https://doi.org/10.7314/apjcp.2014.15.8.3369
  6. Significance of Thrombocytosis in Clinicopathologic Characteristics and Prognosis of Gastric Cancer vol.15, pp.16, 2014, https://doi.org/10.7314/apjcp.2014.15.16.6511
  7. Is thrombocytosis a useful prognostic marker in renal cell carcinoma? Results of a single-center retrospective analysis vol.31, pp.1, 2015, https://doi.org/10.4103/0970-1591.145292
  8. Utility of Peripheral Blood Parameters in Predicting Breast Cancer Risk vol.16, pp.6, 2011, https://doi.org/10.7314/apjcp.2015.16.6.2409
  9. The Association of Platelet Count with Clinicopathological Significance and Prognosis in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis vol.10, pp.5, 2015, https://doi.org/10.1371/journal.pone.0125538
  10. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review vol.10, pp.12, 2011, https://doi.org/10.1371/journal.pone.0143080
  11. Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma vol.50, pp.3, 2011, https://doi.org/10.3109/21681805.2015.1136677
  12. Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma vol.57, pp.5, 2011, https://doi.org/10.4111/icu.2016.57.5.324
  13. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis vol.35, pp.5, 2017, https://doi.org/10.1007/s00345-016-1940-1
  14. Impact of preoperative thrombocytosis on prognosis after surgical treatment in pathological T1 and T2 renal cell carcinoma: results of a multi-institutional comprehensive study vol.8, pp.38, 2011, https://doi.org/10.18632/oncotarget.16136